Menu

Coming soonCare is not live yet. You cannot start treatment, get a prescription or place an order on Livozo today.

Weight loss

Tirzepatide for weight loss.

Compounded tirzepatide is a weekly injection that acts on two gut-hormone receptors. A licensed partner clinician may prescribe it for weight management once care goes live. It is compounded, not a branded FDA-approved product.

  • Compounded
  • Injectable
  • Weekly
  • Coming soon

FDA status. Compounded tirzepatide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are sold, and a compounded version is not a generic of Zepbound or Mounjaro.

Tirzepatide vial illustration
Illustration. Actual medication and packaging may look different.
Form
Injection
Schedule
Once a week
Price
Set by clinical partner
Availability
Coming soon

Everything you need, included

  • An online visit with a licensed clinician
  • Your medication, if prescribed
  • Supplies and discreet shipping
  • Messages with your care team

Care is not live yet. When it opens, a licensed clinician reviews your health history before anything is prescribed.

01

What it is.

Tirzepatide acts on two hormone receptors, GIP and GLP-1, that affect appetite and blood sugar. Zepbound and Mounjaro are FDA-approved branded tirzepatide products.[1]

A compounded version is made by a licensed pharmacy for one patient's prescription. FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before they are marketed.[2][3]

02

What clinicians consider.

A licensed clinician looks at your full picture before deciding anything. These are the kinds of questions they ask. They are not a diagnosis.

  • Your weight history, current weight and health goals
  • Conditions linked to weight, such as sleep apnea, high blood pressure or type 2 diabetes
  • Your personal and family medical history, including thyroid cancer
  • Other medicines you take, including insulin and birth control pills
  • Past use of GLP-1 medicines and how you tolerated them
  • Pregnancy, plans for pregnancy or breastfeeding
03

What the evidence says.

Compounded tirzepatide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are sold, and a compounded version is not a generic of Zepbound or Mounjaro.

In the SURMOUNT-1 trial, adults with obesity and without diabetes took branded tirzepatide weekly for 72 weeks. Average weight loss was 15.0% at 5 mg, 19.5% at 10 mg and 20.9% at 15 mg, compared with 3.1% on placebo. This trial studied the FDA-approved branded product, not compounded tirzepatide.[4]

The most common side effects were stomach and bowel problems. Most were mild to moderate and happened mainly while the dose was being increased.[4]

Limits. These results come from the branded FDA-approved product at set doses. No trial of that size has tested compounded tirzepatide, and compounded products can differ in strength and quality. Results differ from person to person.

04

Risks and when to get help.

The branded label carries a boxed warning: tirzepatide caused thyroid C-cell tumors in rats. It is unknown whether it causes these tumors in people.[1]

The label also lists acute pancreatitis, gallbladder disease, serious allergic reactions, and a risk of breathing in stomach contents during anesthesia or deep sedation. It can make birth control pills work less well for 4 weeks after starting and after each dose increase.[1]

As of May 31, 2026, FDA had received more than 730 adverse event reports tied to compounded tirzepatide.[2]

Tell a clinician if

  • Tell a clinician if you or a family member has had medullary thyroid carcinoma or MEN 2.
  • Tell a clinician if you have had pancreatitis or gallbladder disease.
  • Tell a clinician if you take insulin, a sulfonylurea or birth control pills.
  • Tell a clinician if you have diabetic eye disease or kidney problems.
  • Tell a clinician if you are pregnant, plan to become pregnant or are breastfeeding.
  • Tell a clinician before any surgery or procedure that needs anesthesia or sedation.

Get urgent care if

  • Severe stomach pain that does not go away, with or without vomiting
  • Swelling of the face, lips, tongue or throat, or trouble breathing
  • Vomiting or diarrhea so bad that you cannot keep fluids down
  • Signs of low blood sugar, such as shaking, sweating or confusion
  • A lump or swelling in your neck, or trouble swallowing
05

What care will include.

  • An online health history reviewed by a licensed partner clinician
  • A clinician's decision on whether compounded tirzepatide is appropriate for you
  • If prescribed, a patient-specific prescription filled by a licensed pharmacy
  • Dosing and injection guidance from the partner care team
  • Follow-up to review side effects and progress

What Livozo does not do

  • Livozo does not prescribe, diagnose or dispense medication.
  • Livozo does not decide whether a treatment is right for you. A licensed partner clinician makes that decision.
  • Livozo does not promise a prescription, a delivery date or a result.
  • Livozo does not offer this treatment today. Care is not live.
06

Cost.

Coming soon. There is no checkout today. Livozo's planned platform subscription is $39 the first month, then $79 each month. Medication is billed separately by the clinical partner at their price. Livozo does not mark up medicine.

What a price should include

  • Livozo's planned platform subscription ($39 the first month, then $79 each month)
  • The licensed partner clinician's review
  • The medication itself, billed by the clinical partner at their price if prescribed
  • Needles, syringes and other supplies
  • Shipping from the licensed pharmacy
  • Lab tests, if a clinician orders them
  • Follow-up visits and messages
07

Availability.

Coming soon. Compounded tirzepatide will be available through licensed clinicians when care opens. Care is not live in any state today. After launch, the target is 50-state coverage through licensed partner clinicians. Louisiana and Mississippi block shipping of compounded GLP-1s. This product will not ship to Louisiana or Mississippi.

Review and sources.

Written by
Livozo Editorial
Medical review
TODO(clinical) Reviewer pending. See review status
Published
Last updated
Next review
Set at clinical sign-off
  1. FDA prescribing information (DailyMed) — Zepbound (tirzepatide)
  2. FDA — FDA's concerns with unapproved GLP-1 drugs used for weight loss
  3. FDA — Human drug compounding
  4. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022

Questions about Tirzepatide.

Is compounded tirzepatide the same as Zepbound or Mounjaro?
No. Zepbound and Mounjaro are FDA-approved branded products. Compounded tirzepatide is not FDA-approved and is not a generic or a substitute for either brand.
Can I get tirzepatide from Livozo today?
No. Care is not live in any state today. When it goes live, a licensed partner clinician will decide whether tirzepatide is appropriate for you.
How much will it cost?
Coming soon. Livozo's planned platform subscription is $39 the first month, then $79 each month. Medication, if prescribed, is billed separately by the clinical partner at their price. Livozo does not mark up medicine. See the Pricing page. There is no live billing today.
Is tirzepatide better than semaglutide?
There is no single best choice for everyone. A clinician weighs your history, goals, side effects and other medicines when choosing between them.
Does tirzepatide affect birth control?
The branded label says it can make birth control pills work less well for a time after starting and after each dose increase. Ask a clinician about a backup method.
Can it ship to every state?
The target after launch is 50-state coverage. Louisiana and Mississippi block shipping of compounded GLP-1s. It will not ship to Louisiana or Mississippi.

Keep reading.